Mirum Pharmaceuticals ( NASDAQ:MIRM – Get Free Report ) and ADC Therapeutics ( NYSE:ADCT – Get Free Report ) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, analyst recommendations, valuation, institutional ownership, profitability and earnings.
Valuation and Earnings
This table compares Mirum Pharmaceuticals and ADC Therapeutics”s gross revenue, earnings per share (EPS) and valuation.
Get Mirum Pharmaceuticals alerts:
Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Mirum Pharmaceuticals $521.31 million 11.74 -$23.36 million ($15.47) -6.06
ADC Therapeutics $81.36 million 2.47 -$142.62 million ($0.66) -2.39
Mirum Pharmaceuticals has higher revenue and earnings than ADC Therapeutics. Mirum Pharmaceuticals is trading at a lower price-to-earnings ratio than ADC Therapeutics, indicating that it is currently the more affordable of the two stocks.
Institutional & Insider Ownership
41.1% of ADC Therapeutics shares are owned by institutional investors. 8.3% of Mirum Pharmaceuticals shares are owned by insiders. Comparatively, 5.1% of ADC Therapeutics share...